Tokio Marine Asset Management Co. Ltd. Has $29.59 Million Holdings in UnitedHealth Group Incorporated $UNH

Tokio Marine Asset Management Co. Ltd. cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 5.4% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 85,693 shares of the healthcare conglomerate’s stock after selling 4,913 shares during the period. UnitedHealth Group makes up approximately 1.1% of Tokio Marine Asset Management Co. Ltd.’s portfolio, making the stock its 16th biggest position. Tokio Marine Asset Management Co. Ltd.’s holdings in UnitedHealth Group were worth $29,590,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Bayforest Capital Ltd lifted its holdings in shares of UnitedHealth Group by 685.7% in the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 48 shares in the last quarter. LFA Lugano Financial Advisors SA purchased a new position in UnitedHealth Group during the 2nd quarter worth $25,000. Sagard Holdings Management Inc. purchased a new position in UnitedHealth Group during the second quarter worth about $29,000. Islay Capital Management LLC purchased a new stake in UnitedHealth Group in the 2nd quarter valued at about $31,000. Finally, Riggs Asset Managment Co. Inc. increased its position in shares of UnitedHealth Group by 69.4% during the second quarter. Riggs Asset Managment Co. Inc. now owns 105 shares of the healthcare conglomerate’s stock valued at $33,000 after acquiring an additional 43 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 0.9%

Shares of NYSE UNH opened at $343.83 on Monday. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $606.36. The firm has a market capitalization of $311.46 billion, a price-to-earnings ratio of 17.95, a PEG ratio of 2.08 and a beta of 0.42. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 0.71. The business has a 50-day moving average of $329.51 and a 200-day moving average of $321.33.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. The firm had revenue of $113.16 billion for the quarter, compared to analyst estimates of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The business’s revenue for the quarter was up 12.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $7.15 EPS. Sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 16th. Investors of record on Monday, December 8th were given a $2.21 dividend. The ex-dividend date was Monday, December 8th. This represents a $8.84 dividend on an annualized basis and a yield of 2.6%. UnitedHealth Group’s payout ratio is presently 46.14%.

UnitedHealth Group News Summary

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth released two independent Milliman actuarial studies finding Medicare Advantage costs the government less and lowers beneficiaries’ out-of-pocket costs, which the company is using to defend the value of its MA business and to counter regulatory criticism. New Independent Studies: Medicare Advantage Delivers Greater Value to the Federal Government and Beneficiaries than Traditional Medicare
• Neutral Sentiment: Brokerage coverage remains generally constructive (average rating reported as “Moderate Buy”), suggesting analysts still expect earnings growth despite near-term headline risk. UnitedHealth Group Incorporated (NYSE:UNH) Given Average Rating of “Moderate Buy” by Brokerages
• Neutral Sentiment: Sector momentum commentary (healthcare rebound / ETFs) highlights tailwinds for major insurers from drug and services trends; this supports sentiment for large diversified players like UNH but is a broader factor rather than company-specific. This ETF Is Proof That the Healthcare Rebound Is Real (UNH)
• Negative Sentiment: A Senate committee report (reported by Reuters and the WSJ) says UnitedHealth used aggressive tactics to capture diagnoses that boost Medicare Advantage payments — allegations that increase the risk of congressional scrutiny, investigations, fines or required repayment and could pressure margins and the stock. Senate report says UnitedHealth used aggressive tactics to boost medicare payments, WSJ reports UnitedHealth Group deployed aggressive tactics to collect payment-boosting diagnoses for its Medicare Advantage members, a Senate committee investigating the company’s practices said

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on UNH. Bank of America raised their target price on UnitedHealth Group from $350.00 to $390.00 and gave the company a “neutral” rating in a research report on Wednesday, October 8th. UBS Group lifted their price objective on shares of UnitedHealth Group from $378.00 to $430.00 and gave the stock a “buy” rating in a research report on Wednesday, October 29th. Barclays upped their price objective on UnitedHealth Group from $386.00 to $391.00 and gave the company an “overweight” rating in a research note on Monday, January 5th. Piper Sandler cut their price target on UnitedHealth Group from $423.00 to $417.00 and set an “overweight” rating for the company in a research note on Tuesday, October 28th. Finally, KeyCorp upped their price objective on shares of UnitedHealth Group from $350.00 to $400.00 and gave the company an “overweight” rating in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, nine have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $385.75.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.